Bio Techne Corp Stock Market Value
| TECH Stock | USD 62.54 0.68 1.10% |
| Symbol | Bio |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bio Techne 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Techne's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Techne.
| 07/23/2025 |
| 10/21/2025 |
If you would invest 0.00 in Bio Techne on July 23, 2025 and sell it all today you would earn a total of 0.00 from holding Bio Techne Corp or generate 0.0% return on investment in Bio Techne over 90 days. Bio Techne is related to or competes with Revolution Medicines, Caris Life, Madrigal Pharmaceuticals, Biomarin Pharmaceutical, Corcept Therapeutics, Moderna, and Exelixis. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instrum... More
Bio Techne Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Techne's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Techne Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.65 | |||
| Information Ratio | 0.0744 | |||
| Maximum Drawdown | 14.43 | |||
| Value At Risk | (4.41) | |||
| Potential Upside | 5.7 |
Bio Techne Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Techne's standard deviation. In reality, there are many statistical measures that can use Bio Techne historical prices to predict the future Bio Techne's volatility.| Risk Adjusted Performance | 0.0736 | |||
| Jensen Alpha | 0.2879 | |||
| Total Risk Alpha | (0.03) | |||
| Sortino Ratio | 0.0806 | |||
| Treynor Ratio | (5.83) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne Corp Backtested Returns
Bio Techne appears to be very steady, given 3 months investment horizon. Bio Techne Corp secures Sharpe Ratio (or Efficiency) of 0.0828, which signifies that the company had a 0.0828 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Bio Techne Corp, which you can use to evaluate the volatility of the firm. Please makes use of Bio Techne's Risk Adjusted Performance of 0.0736, downside deviation of 2.65, and Mean Deviation of 2.0 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bio Techne holds a performance score of 6. The firm shows a Beta (market volatility) of -0.0488, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bio Techne are expected to decrease at a much lower rate. During the bear market, Bio Techne is likely to outperform the market. Please check Bio Techne's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Bio Techne's price patterns will revert.
Auto-correlation | 0.01 |
Virtually no predictability
Bio Techne Corp has virtually no predictability. Overlapping area represents the amount of predictability between Bio Techne time series from 23rd of July 2025 to 6th of September 2025 and 6th of September 2025 to 21st of October 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Techne Corp price movement. The serial correlation of 0.01 indicates that just 1.0% of current Bio Techne price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.01 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 18.49 |
Bio Techne Corp lagged returns against current returns
Autocorrelation, which is Bio Techne stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Techne's stock expected returns. We can calculate the autocorrelation of Bio Techne returns to help us make a trade decision. For example, suppose you find that Bio Techne has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Techne regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Techne stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Techne stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Techne stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Techne Lagged Returns
When evaluating Bio Techne's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Techne stock have on its future price. Bio Techne autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Techne autocorrelation shows the relationship between Bio Techne stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Techne Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:Check out Bio Techne Correlation, Bio Techne Volatility and Bio Techne Alpha and Beta module to complement your research on Bio Techne. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Bio Techne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.